These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 23918746)
1. Small intragenic deletion in FOXP2 associated with childhood apraxia of speech and dysarthria. Turner SJ; Hildebrand MS; Block S; Damiano J; Fahey M; Reilly S; Bahlo M; Scheffer IE; Morgan AT Am J Med Genet A; 2013 Sep; 161A(9):2321-6. PubMed ID: 23918746 [TBL] [Abstract][Full Text] [Related]
2. FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrum. Reuter MS; Riess A; Moog U; Briggs TA; Chandler KE; Rauch A; Stampfer M; Steindl K; Gläser D; Joset P; ; Krumbiegel M; Rabe H; Schulte-Mattler U; Bauer P; Beck-Wödl S; Kohlhase J; Reis A; Zweier C J Med Genet; 2017 Jan; 54(1):64-72. PubMed ID: 27572252 [TBL] [Abstract][Full Text] [Related]
3. Case Report: Expressive Speech Disorder in a Family as a Hallmark of 7q31 Deletion Involving the Nagy O; Kárteszi J; Elmont B; Ujfalusi A Front Pediatr; 2021; 9():664548. PubMed ID: 34490154 [TBL] [Abstract][Full Text] [Related]
4. Phenotype of FOXP2 haploinsufficiency in a mother and son. Rice GM; Raca G; Jakielski KJ; Laffin JJ; Iyama-Kurtycz CM; Hartley SL; Sprague RE; Heintzelman AT; Shriberg LD Am J Med Genet A; 2012 Jan; 158A(1):174-81. PubMed ID: 22106036 [TBL] [Abstract][Full Text] [Related]
5. In-depth characterisation of a cohort of individuals with missense and loss-of-function variants disrupting Morison LD; Meffert E; Stampfer M; Steiner-Wilke I; Vollmer B; Schulze K; Briggs T; Braden R; Vogel A; Thompson-Lake D; Patel C; Blair E; Goel H; Turner S; Moog U; Riess A; Liegeois F; Koolen DA; Amor DJ; Kleefstra T; Fisher SE; Zweier C; Morgan AT J Med Genet; 2023 Jun; 60(6):597-607. PubMed ID: 36328423 [TBL] [Abstract][Full Text] [Related]
6. Speech, prosody, and voice characteristics of a mother and daughter with a 7;13 translocation affecting FOXP2. Shriberg LD; Ballard KJ; Tomblin JB; Duffy JR; Odell KH; Williams CA J Speech Lang Hear Res; 2006 Jun; 49(3):500-25. PubMed ID: 16787893 [TBL] [Abstract][Full Text] [Related]
7. Functional genetic analysis of mutations implicated in a human speech and language disorder. Vernes SC; Nicod J; Elahi FM; Coventry JA; Kenny N; Coupe AM; Bird LE; Davies KE; Fisher SE Hum Mol Genet; 2006 Nov; 15(21):3154-67. PubMed ID: 16984964 [TBL] [Abstract][Full Text] [Related]
8. Novel candidate genes and regions for childhood apraxia of speech identified by array comparative genomic hybridization. Laffin JJ; Raca G; Jackson CA; Strand EA; Jakielski KJ; Shriberg LD Genet Med; 2012 Nov; 14(11):928-36. PubMed ID: 22766611 [TBL] [Abstract][Full Text] [Related]
9. Novel FOXP2 variant associated with speech and language dysfunction in a Chinese family and literature review. Che F; Li C; Zhang L; Qian C; Mo L; Li B; Wu H; Wang L; Yang Y J Appl Genet; 2024 May; 65(2):367-373. PubMed ID: 38418803 [TBL] [Abstract][Full Text] [Related]
10. Childhood Apraxia of Speech (CAS) in two patients with 16p11.2 microdeletion syndrome. Raca G; Baas BS; Kirmani S; Laffin JJ; Jackson CA; Strand EA; Jakielski KJ; Shriberg LD Eur J Hum Genet; 2013 Apr; 21(4):455-9. PubMed ID: 22909774 [TBL] [Abstract][Full Text] [Related]
11. 7q31.2q31.31 deletion downstream of FOXP2 segregating in a family with speech and language disorder. Rieger M; Krumbiegel M; Reuter MS; Schützenberger A; Reis A; Zweier C Am J Med Genet A; 2020 Nov; 182(11):2737-2741. PubMed ID: 32885567 [TBL] [Abstract][Full Text] [Related]
12. Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits. MacDermot KD; Bonora E; Sykes N; Coupe AM; Lai CS; Vernes SC; Vargha-Khadem F; McKenzie F; Smith RL; Monaco AP; Fisher SE Am J Hum Genet; 2005 Jun; 76(6):1074-80. PubMed ID: 15877281 [TBL] [Abstract][Full Text] [Related]
13. Monoallelic expression of the human FOXP2 speech gene. Adegbola AA; Cox GF; Bradshaw EM; Hafler DA; Gimelbrant A; Chess A Proc Natl Acad Sci U S A; 2015 Jun; 112(22):6848-54. PubMed ID: 25422445 [TBL] [Abstract][Full Text] [Related]
14. Assessing the impact of FOXP1 mutations on developmental verbal dyspraxia. Vernes SC; MacDermot KD; Monaco AP; Fisher SE Eur J Hum Genet; 2009 Oct; 17(10):1354-8. PubMed ID: 19352412 [TBL] [Abstract][Full Text] [Related]
15. Severe speech impairment is a distinguishing feature of FOXP1-related disorder. Braden RO; Amor DJ; Fisher SE; Mei C; Myers CT; Mefford H; Gill D; Srivastava S; Swanson LC; Goel H; Scheffer IE; Morgan AT Dev Med Child Neurol; 2021 Dec; 63(12):1417-1426. PubMed ID: 34109629 [TBL] [Abstract][Full Text] [Related]